{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:55:04Z","timestamp":1759366504299,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.revmed.2022.03.338","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T17:26:38Z","timestamp":1657560398000},"page":"596-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acrosyndromes vasculaires paroxystiques\u00a0: d\u00e9marche pratique de diagnostic et de prise en charge"],"prefix":"10.1016","volume":"43","author":[{"given":"P.","family":"Senet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2022.03.338_bib0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.annder.2013.02.010","article-title":"Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation working group of the Soci\u00e9t\u00e9 fran\u00e7aise de m\u00e9decine vasculaire","volume":"140","author":"Pistorius","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud's phenomenon","volume":"375","author":"Wigley","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2022.03.338_bib0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MD.0b013e31815c95d3","article-title":"Long-term follow-up of hypothenar hammer syndrome: a series of 47\u00a0patients","volume":"86","author":"Marie","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2022.03.338_bib0175","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s10067-019-04745-5","article-title":"Raynaud's phenomenon-an update on diagnosis, classification and management","volume":"38","author":"Pauling","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0180","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586\u00a0patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"suppl 10","key":"10.1016\/j.revmed.2022.03.338_bib0185","article-title":"Predictors to develop definite Systemic Sclerosis (SSc): results from an International Multicentre Study on Very Early DiagnOsis of Systemic Sclerosis (VEDOSS)","volume":"71","author":"Bellando-Randone","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0190","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/rheumatology\/kep447","article-title":"Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy","volume":"49","author":"Ingegnoli","year":"2010","journal-title":"Rheumatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0195","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"suppl 2","key":"10.1016\/j.revmed.2022.03.338_bib0200","first-page":"322","article-title":"French recommandations for the management of systemic sclerosis Orphanet","volume":"16","author":"Hachulla","year":"2021","journal-title":"J Rare Dis"},{"key":"10.1016\/j.revmed.2022.03.338_bib0205","first-page":"CD000467","article-title":"Calcium channel blockers for primary and secondary Raynaud's phenomenon","volume":"12","author":"Rirash","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2022.03.338_bib0210","first-page":"CD006687","article-title":"Vasodilatators for primary Raynaud's phenomenon","volume":"5","author":"Yc Su","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2022.03.338_bib0215","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.semarthrit.2018.03.019","article-title":"Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: systematic literature review and expert consensus","volume":"48","author":"Ingegnoli","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2022.03.338_bib0220","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00296-015-3241-1","article-title":"Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review","volume":"35","author":"Garcia de la Pena Lefebvre","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2022.03.338_bib0225","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","article-title":"Consensus best practice pathway of the UK scleroderma study group: digital vasculopathy in systemic sclerosis","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0230","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/annrheumdis-2012-202836","article-title":"Phosphodiesterase-5\u00a0inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of controlled trials","volume":"72","author":"Roustit","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2022.03.338_bib0235","doi-asserted-by":"crossref","first-page":"101684","DOI":"10.1016\/j.berh.2021.101684","article-title":"Botulinum toxin in the management of primary and secondary Raynaud's phenomenon","volume":"35","author":"Ennis","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0240","first-page":"159","article-title":"Erythermalgia (erythromelalgia). Redefining the classification of adult erythromelalgia","volume":"46","author":"Lazareth","year":"2021","journal-title":"J Med Vasc"},{"key":"10.1016\/j.revmed.2022.03.338_bib0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1468-3083.2008.02938.x","article-title":"Incidence of erythromelalgia: a population-based study in Olmsted County, Minnesota","volume":"23","author":"Reed","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0250","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archderm.136.3.330","article-title":"Natural history of erythromelalgia. Presentation and outcome in 168\u00a0patients","volume":"136","author":"Davis","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0255","first-page":"632","article-title":"Microvascular imaging of primary erythromelalgia","volume":"129","author":"Hellmann","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.revmed.2022.03.338_bib0260","first-page":"1337","article-title":"Erythromelalgia: vasculopathy, neuropathy, or both?","volume":"139","author":"Davies","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0265","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.0022-202X.2004.22339.x","article-title":"The prostaglandin E1\u00a0analog misoprostol reduces symptoms and microarteriovenous shunting in erythromelalgia- a double-blind, crossover, placebo-compared study","volume":"122","author":"Mork","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0270","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ced.13891","article-title":"Review of primary and secondary erythromelalgia","volume":"44","author":"Mann","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neucli.2021.03.008","article-title":"A reappraisal of the presence of small or large fiber neuropathy in patients with erythromelalgia","volume":"51","author":"Reach","year":"2021","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.revmed.2022.03.338_bib0280","first-page":"80","article-title":"Clinical features and management of erythromelalgia: long-term follow-up of 46\u00a0cases","volume":"35","author":"Parker","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0285","first-page":"1583","article-title":"Thermoregulatory sweat testing in patients with erythromelalgia","volume":"142","author":"Davis","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0290","first-page":"350","article-title":"Results of computer-assisted sensory evaluation in 41\u00a0patients with erythromelalgia","volume":"37","author":"Genebriera","year":"2012","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.revmed.2022.03.338_bib0295","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/jdv.17714","article-title":"Cutaneous manifestations of small-fiber polyneuropathy","volume":"36","author":"Akabane","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0300","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.annder.2015.06.006","article-title":"Diagnostic des acrosyndromes vasculaires","volume":"142","author":"Senet","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2022.03.338_bib0305","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MD.0000000000025659","article-title":"Digital ischaemia aetiologies and mid-term follow-up","volume":"100","author":"Raimbeau","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2022.03.338_bib0155","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/MD.0000000000000047","article-title":"Digital ischemia associated with cancer: results from a cohort study","volume":"93","author":"Le Besnerais","year":"2014","journal-title":"Medicine (Baltimore)"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:45:17Z","timestamp":1759337117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0248866322000832"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.03.338","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acrosyndromes vasculaires paroxystiques\u00a0: d\u00e9marche pratique de diagnostic et de prise en charge","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.03.338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}